Therapy of brain tumors in dogs and cats

Vlaams Diergeneeskundig Tijdschrift

Volumn 76, Issue 3, 2007, Pages 165-176

  Van Meervenne, S A E ^a   De Vos, J P ^b   Van Ham, L M L ^a  

^a GHENT UNIVERSITY   (Belgium)

^b De Ottenhorst   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 34547509156     PISSN: 03039021     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Axlund T.W., McGlasson M.L., Smith A.N. (2002). Surgery alone or in combination with radiation therapy for treatment of intracranial meningiomas in dogs: 31 cases (1989-2002). Journal of the American Veterinary Medicine Association 221, 1597-1600.
2. Brearly M.J., Jeffery N.D., Phillips S.M., Dennis R. (1999). Hypofractionated radiation therapy of brain masses in dogs: a retrospective analysis of survival of 83 cases (1991-1996). Journal of Veterinary Internal Medicine 13, 408-412.
3. Carde P., Timmerman R., Mehta M.P., Koprowski C.D., Ford J., Tishler R.B., Miles D., Miller R.A., Renschler M.F. (2001). Multicenter phase Ib/II trial of radiation enhancer motexafin gadolinium in patients with brain metastases. Journal of Clinical Oncology 19, 2074-2083.
4. Chauvet A.E., Kesava P.P., Goh C.S., Badie B. (1998). Selective intraarterial gene delivery into a canine meningioma. Journal of Neurosurgery 88, 870-873.
5. Cook J.R. (1990). Chemotherapy for brain tumors. Veterinary medicine report 2, 391-396.
6. Couto C.G., Cullen J., Pedroia V., Turrel J.M. (1984). Central nervous system lymphosarcoma in the dog. Journal of the American Veterinary Medicine Association 184,809-813.
7. Culver B.C., Inzana K., Jones J., Troy G., Kroll R., Culver B., Jortner B. (1998). Technique of, and complications attributable to, repeated hyperosmotic blood-brain barrier disruption in dogs. American Journal of Veterinary Research 59, 1503-1510.
8. Dimski D.S. and Cook J.R. (1990). Carmustine-induced partial remission of an astrocytoma in a dog. Journal of the American Animal Hospitalisation Association 26, 179-182.
9. Dropcho E.J. (2001). Novel chemotherapeutic approaches to brain tumors. Hematology/Oncology Clinics of North America 15, 1027-1051.
10. Evans S.M., Dayrell-Hart B., Powlis W., Christy G., VanWinckle T. (1993). Radiation therapy of canine brain masses. Journal of Veterinary Internal Medicine 7, 216-219.
11. Fan T.M., Kitchell B.E. (2000). Pharm profile: Lomustine. Compendium on Continuing Education for the Practising Veterinarian 22, 934-936.
12. Fan T.M., Kitchell B.E., Dhaliwal R.S., Jones P.D., Hintermeister J.G., Paria B.C. (2002). Hematological toxicity and therapeutic efficacy of lomustine in 20 tumor-bearing cats: critical assessment of a practical dosing regimen. Journal of the American Animal Hospitalisation Association 38, 357-363.
13. Feder B.M., Fry T.R., Kostolich M., Bartels K.E., Bahr R.J., Mandsager R.E., Paranjpe M., Ewing P.J., Schoenhals J. (1993). Nd: YAG Laser cytoreduction of an invasive intracranial meningioma in a dog. Progress in Veterinary Neurology 4, 3-9.
14. Foster E.S., Carillo J.M., Patnark A.K. (1988). Signs of tumors affecting the rostral cerebrum in 43 dogs. Journal of Veterinary Internal Medicine 2, 71-74.
15. Fransson B.A., Bagley R.S., Gay J.M., Silver G.M., Gokhale S., Sanders S. Gavin P.R. (2001). Pneumonia after intracranial surgery in dogs. Veterinary Surgery 30, 432-439.
16. Fulton L.M. and Steinberg H.S. (1990). Preliminary study of lomustine in the treatment of intracranial masses in dogs following localization by imaging techniques. Seminars in Veterinary Medicine and Surgery: Small Animal 5, 241-245.
17. Fusco J.V., Hohenhaus A.E., Aiken S.W., Joseph R.J., Berg J.M. (2000). Autologous blood collection and transfusion in cats undergoing partial craniectomy. Journal of the American Veterinary Medicine Association 216, 1584-1588.
18. Gallager J.G., Berg J., Knowles K.E., Williams L.L., Branson R.T. (1993). Prognosis after surgical excision of cerebral meningioma in cats: 17 cases. Journal of the American Veterinary Medicine Association 203, 1437-1440.
19. Gavin P.R., Fike J.R., Hoopes P.J. (1995). Central nervous system tumors. Seminars in Veterinary Medicine and Surgery: Small Animal 10, 180-189.
20. Giannopoulou C. (2003). The role of SPET and PET in monitoring tumour response to therapy. European Journal of Nuclear Medicine and Molecular Imaging 30, 1173-1200.
21. Glass E.N., Kapatkin A., Vite C., Steinberg S.A. (2000). A modified bilateral transfrontal sinus approach to the canine frontal lobe and olfactory bulb: surgical technique and five cases. Journal of the American Animal Hospitalisation Association 36, 43-50.
22. Gordon L.E., Thacher C., Matthiesen D.T, Joseph R.J. (1994). Results of craniotomy for the treatment of cerebral meningioma in 42 cats. Veterinary Surgery 23, 94-100.
23. Gordon P.N., Kornegay J.N., Lattimer J.C., Cook C.R., Tucker-Warhover T. (2005). Use of a rivet-like titanium clamp closure system to replace an external frontal bone flap after transfrontal craniotomy in a dog. Journal of the American Veterinary Medicine Association 226, 752-755.
24. Groothuis D.R., Warkne P.C., Molnar P., Lapin G.D., Mikhael M.A. (1990). Effect of hyperosmotic blood-brain barrier disruption on transcapillary transport in canine brain tumors. Journal of Neurosurgery 72, 441-449.
25. Hanson J.M., van't Hoofd M.M., Voorhout G., Teske E., Kooistra H.S., Meij B.P. (2005). Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism. Journal of Veterinary Internal Medicine 19, 687-694.
26. Harvey R.C., Sims M.H., Greene S.A. (1996). Neurologic disease. In: Thurmon J.C., Tranquill W.C., Benson G.J. (editors). Lumb & Jones' Veterinary Anesthesia. Third edition, Lippincott Williams & Wilkins, Philadelphia, p. 775-781.
27. Heidner G.L., Kornegay J.N., Page R.L., Dodge R.K., Thrall D.E. (1991). Analysis of survival in a retrospective study of 86 dogs with brain tumors. Journal of Veterinary Internal Medicine 5, 219-226.
28. rd Edition, W.B. Saunders Company, Philadelphia, Pennsylvania, p. 138-168.
29. Inamura T., Black K.L. (1994). Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. Journal of Cerebral Blood Flow Metabolism 14, 862-870.
30. Iwamoto K.S., Norman A., Freshwater D.B., Ingram M., Skillen R.G. (1993). Diagnosis and treatment of spontaneous canine brain tumors with a CT scanner. Radiotherapy and Oncology 26, 76-78.
31. Jarden J.O., Dhawan V., Moeller J.R., Strother S.C., Rottenberg D.A. (1989). The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: a positron emission tomographic study. Annuals of Neurology 25, 239-245.
32. Jeffery N., Brearley M.J. (1993). Brain tumours in the dog: treatment of 10 cases and review of recent literature. Journal of Small Animal Practice 34, 367-372.
33. Jiminez D., Higgins R., LeCouteur R.A., Fick J., Dwarki V. (1998). Bystander killing in canine meningioma cells with a recombinant adeno-associated virus vector containing herpes simplex viral thymindine kinase [rAAV- HSV-tk]. Veterinary Pathology 35, 443.
34. Klopp L.S., Simpson S.T., Sorjonen D.C., Lenz S.D. (2000). Ventral surgical approach to the caudal brain stem in dogs. Veterinary Surgery 29, 533-542.
35. Kostolich M., Dulisch M.L. (1987). A surgical approach to the canine olfactory bulb for meningioma removal. Veterinary Surgery 16, 273-277.
36. Kristal O., Rassnick K.M., Gliatto J.M., Northrup N.C., Chretin J.D., Morrison-Collister K., Cotter S.M., Moore A.S. (2004). Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. Journal of Veterinary Internal Medicine 18, 75-80.
37. Kroll R.A., Neuwelt E.A. (1998). Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42, 1083-1099.
38. LaRue S.M. and Gillette E.L. (1993). Recent advances in radiation oncology. Compendium on Continuing Education for the Practising Veterinarian 15, 795-804.
39. Lawson D.C., Burk R.L., Prata R.G. (1982). Cerebral meningioma in the cat: diagnosis and surgical treatment often cases. Journal of the American Animal Hospitalisation Association 20, 333-342.
40. LeCouteur R.A. (1999). Current concepts in the diagnosis and treatment of brain tumours in dogs and cats. Journal of Small Animal Practice 40, 411-416.
41. th Congress of the European College of Veterinary Internal Medicine, Barcelona, September 9-11.
42. Macdonald D.R. (2001). Temozolomide for recurrent high-grade glioma. Seminars in Oncology 28, suppl 13, 3-12.
43. Mealey K.L., Northrup N.C., Bentjen S.A. (2003). Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity. Journal of the American Veterinary Medicine Association 223, 1453-1455.
44. Mealey K.L. (2006). Adverse drug reactions in herding-breed dogs: the role of P-Glycoprotein. Compendium on Continuing Education for the Practising Veterinarian 28, 23-33.
45. Meij B.P., Voorhout G., van den Ingh TSGAM, Hazewinkel H.A., Van't Verlaat J.W. (1997). Transsphenoidal hypophysectomy in beagle dogs: Evaluation of a microsurgical technique. Veterinary Surgery 26, 295-309.
46. Meij B.P., Voorhout G., Van den Ingh T.S., Hazewinckel H.A., Teske E., Rijnberk A. (1998). Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependant hyperadrenocorticism. Veterinary Surgery 27, 246-261.
47. Meij B.P., Voorhout G., Rijnberk A. (2002). Progress in transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in dogs and cats. Molecular and Cellular Endocrinology 1997, 89-96.
48. Merker P.C., Wodinsky I., Geran R.I. (1975). Review of selected experimental brain tumor models used in chemotherapy experiments. Cancer Chemotherapy Report 59, 729-736.
49. Milas L., Mason K.A., Liao Z., Ang K.K. (2003). Chemoradiotherapy: emerging treatment improvement strategies. Head Neck 25, 152-167.
50. Morrison W.B. (2002). Selecting the best cancer treatment. In: Williams & Wilkins (editors). Cancer in Dogs and Cats: Medical and Surgical Management. 2nd ed., Baltimore, Maryland, p. 205-208.
51. Mouatt J.G. (2002). Acrylic cranioplasty and axial pattern flap following calvarial and cerebral mass excision in a dog. Australian Veterinary Journal 80, 211-215.
52. Nakaichi M., Taura Y., Nakanma S., Takeuchi A., Matsunaga N., Ebe K., Amimoto A., (1996). Primary brain tumors in two dogs treated by surgical resection in combination with postoperative radiation therapy. Journal of Veterinary Medicine Science 58, 773-775.
53. Neuwelt E.A., Goldman D.L., Dahlborg S.A., Crossen J., Ramsey F., Roman-Goldstein S., Braziel R., Dana B. (1991). Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. Journal of Clinical Oncology 9, 1580-1590.
54. Niebauer G.W., Dayrell-Hart B.L., Speciale J. (1991). Evaluation of craniotomy in dogs and cats. Journal of the American Veterinary Medicine Association 198, 89-95.
55. Parker A.J. (1990). Treatment of brain tumors and encephalitis in the dog and cat. Progress in Veterinary Neurology 1, 133-136.
56. th Annual Meeting, European Society and College of Veterinary Neurology, September 23-24, Prague.
57. Platt S.R. (2005). Angiogenesis and cerebral neoplasia. Veterinary and Comparative Oncology 3, 123-138.
58. Rapaport S.I. (1990). Blood-brain barrier disruption in brain-tumor therapy. Journal of Neurosurgery 73, 475-477.
59. th Congress of the European College of Veterinary Internal Medicine, Barcelona, September 9-11.
60. Rohrer Bley C., Sumova A., Roos M., Kaser-Hotz B (2005). Irradiation of brain tumors in dogs with neurologic disease. Journal of Veterinary Internal Medicine 19, 849-854.
61. Schneider S.W., Ludwig T., Tatenhorst L., Braune S., OberÚithner H., Senner V., Paulus W. (2004). Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathologica (Berl) 107, 272-276.
62. Selker R.G., Moore P., Lodolce D. (1978). Bone-marrow depression with cimetidine plus carmustine. New English Journal of Medicine 299, 834.
63. Shores A. (1991a). Use of the ultrasonic aspirator in intracranial surgery: technique and case reports. Progress in Veterinary Neurology 2, 89-94.
64. Shores A. (1991b). Intsrumentation for intracranial surgery. Progress in Veterinary Neurology 2, 175-183.
65. Snyder J.M., Shofer F.S., Van Winkle T.J., Massicotte C. (2006). Canine intracranial primary neoplasia: 173 cases (1986-2003).Journal of Veterinary Internal Medicine 20, 669-675.
66. Sorjonen D.C., Thomas W.B., Meyers L.J., Cox N.R. (1991). Radical cortical ressection in dogs. Progress in Veterinary Neurology 2, 225-236.
67. Speciale J., Koffman B.M., Bashirelahi N., Steinberg S.A. (1990). Identification of gonadal steroid receptors in meningiomas from dogs and cats. American Journal of Veterinary Research 51, 833-835.
68. Spugnini E.P., Thrall D.E., Price S.G., Sharp N.J., Munana K., Page R.L. (2000). Primary irradiation of canine intracranial masses. Veterinary Radiology & Ultrasound 41, 377-380.
69. Story M.D., Voehringer D.W., Stephens L.C., Meyn R.E. (1993). L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemotherapy and Pharmacology 32, 129-133.
70. Stupp R., Newlands E. (2001). New approaches for temozolomide therapy: use in newly diagnosed glioma. Seminars in Oncology 28, suppl 13, 19-23.
71. Theon A., Griffey S., LeCouteur R.A., Metzter L. (1997). Radiation therapy of incompleteley resected meningiomas: influence of tumor cell proliferation. Veterinary Cancer Society, Chicago, III: 103.
72. Turrel J.M., LeCouteur R.A., Pflugfelder C.M., Borcick J.K. (1984). Radiotherapy of brain tumors in dogs. Journal of the American Veterinary Medicine Association 184, 82-86.
73. Van de Wiele C., Lahorte C., Oyen W., Boerman O., Goethals I., Siegers G., Dierckx R.A. (2003). Nuclear medicine imaging to predict response to radiotherapy: a review. International Journal of Radiation Oncology Biology Physics 55, 5-15.
74. Vandevelde M. (1984). Brain tumors in domestic animals: an overview. Proceedings, Conference on Brain Tumors in Man and Animals, Research Triangle Park, North Carolina, September 5-6, 1984.
75. Van Meervenne S.A.E, Van Bree H., Van Ham L.M.L. (2005a). Diagnosis of brain tumors in dogs and cats: a review of the literature. Vlaams Diergeneeskundig Tijdschrift 74, 193-204.
76. th Annual Meeting, European Society and College of Veterinary Neurology, September 23-24, Munich.
77. Weiss R.B., Issell B.F. (1982). The nitrosoureas: carmustine (BCNU) and lomustine (CCNU). Cancer Treatment Reviews 9, 313-330.
78. Yamada K., Ushio Y., Hayakawa T., Kato A., Yamada N., Mogami H. (1982). Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model. Journal of Neurosurgery 57, 394-398.
79. Zeltzer P.M., Feig S.A. (1979). Theophyllin-induced lomustine toxicity. Lancet ii, 960-961.